Search Results 71-80 of 18966 for Hepatitis C

  1. A Registry for Cirrhosis that has a Sustained Virologic Response Following Sofosbuvir-Based Treatment without Interferon, for Patients who have Chronic Hepatitis C Infection - Mayo Clinic

    ... Hepatitis C Infection. Print details. Share; Facebook · Twitter. Overview ... hepatitis C virus study or commercially at selected sites. Once enrolled, the ...

  2. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C - Mayo Clinic

    To determine the prevalence of MBL in patients with chronic hepatitis C who are to begin therapy with DAA, and compare with clinic controls who are seen in the ...

  3. 4/16/16 #MayoClinicRadio Podcast: Hep C, Food Allergies, Hemorrhoids - Mayo Clinic News Network

    On Mayo Clinic Radio, infectious diseases specialist Dr. Stacey Rizza outlines the risk factors for contracting hepatitis C, especially for people born between ...

  4. A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus Infection - Mayo Clinic

    A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus ...

  5. A Registry for Participants with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection - Mayo Clinic

    ... Hepatitis C Infection. Print details. Share; Facebook · Twitter. Overview ... hepatitis C virus (HCV) study or commercially at selected sites. Once enrolled ...

  6. Mayo Clinic Minute: ABCs of hepatitis VIDEO AUDIO Approximately 5.3 million people in the US have hepatitis. Stacey Rizza, M.D.

    vaccine for hepatitis B.” Hepatitis C is transmitted from person to person through bodily fluids. The virus can cause liver damage and death. “We do not ...

  7. 'Our goal is to achieve a world without viral hepatitis' - Mayo Clinic News Network

    In the U.S., the Centers for Disease Control and Prevention recommends screening all adults for hepatitis C and all people who were born or lived in a country ...

  8. A Study Comparing Measurements of Response to Antiviral Treatments for Liver Transplant Patients that have Recurrent Hepatitis C - Mayo Clinic

    A Study Comparing Measurements of Response to Antiviral Treatments for Liver Transplant Patients that have Recurrent Hepatitis C · Overview · Participation ...

  9. cancer and luck Archives - Mayo Clinic News Network

    one of several hepatitis viruses, is generally considered to be the most serious. Left untreated, hepatitis C can cause serious liver damage, cirrhosis and even ...

  10. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...